Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 12, Special Issue 8 (2023)

Therapeutic management of clinical mastitis in buffaloes

Author(s):
Vittal, Vivek R Kasaralikar, Patil NA, Ravindra BG, Sandeep H, Dilipkumar D, Shrikant Kulkarni and Sarita
Abstract:
In total, 48 buffaloes were used in this investigation, all of whom had clinical mastitis as determined by the obvious abnormalities in milk discharges. The udder was cleaned, dried with a fresh towel, and the teats were sprayed with 70% ethanol before being examined. After that, the first few milk strips were discarded, and sterile vials containing 50 ml of milk samples from each quadrant were collected and transported immediately to the laboratory. Bacteriological examination and PCR confirms S. aureus (19) was discovered to be the main bacterium present in milk samples, followed by E. coli (13), Streptococcus spp., (09) and Pseudomonas aeruginosa (7). These buffaloes which were positive for clinical mastitis were considered for therapeutic trials and selected buffaloes were randomly allocated into six groups. Group I treated with enrofloxacin 5mg/kg for 5 days, group II with cetfizoxime 10mg/kg once in 3 days, group III with marbofloxacin 8mg/kg once in 3 days and groups IV, V and VI receives same antibiotic with Vit E and selenium respectively and all the groups receives same supportive therapy. antibiotics such as marbofloxacin and Ceftizixime along with antioxidants i.e. Vit E and Se showed early improvement by clinical, haematobiochemical and in oxidative enzyme status compared to antibiotics alone.
Pages: 1305-1308  |  208 Views  133 Downloads
How to cite this article:
Vittal, Vivek R Kasaralikar, Patil NA, Ravindra BG, Sandeep H, Dilipkumar D, Shrikant Kulkarni and Sarita. Therapeutic management of clinical mastitis in buffaloes. The Pharma Innovation Journal. 2023; 12(8S): 1305-1308.

Call for book chapter